当前位置: X-MOL 学术Psychosis › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Re-starting the conversation: improving shared decision making in antipsychotic prescribing
Psychosis ( IF 1.2 ) Pub Date : 2021-03-27 , DOI: 10.1080/17522439.2021.1903979
Lisa Marie Grünwald 1 , Jemima Thompson 2
Affiliation  

ABSTRACT

Shared Decision-Making (SDM) is one of the key components of patient-centred care. People diagnosed with schizophrenia/psychosis still face significant barriers to achieving this, particularly when it comes to antipsychotic medication prescribing. These barriers include issues such as stigma, feelings of coercion and lack of information. Clinicians also describe barriers to achieving SDM in antipsychotic prescribing, including a lack of training and support. In this viewpoint article, we provide a summary of these barriers from the perspectives of both service users and clinicians based. We suggest that, to make a practical first step towards achieving SDM, the conversation around antipsychotic prescribing needs to be re-started. However, the onus to do this should not be placed solely on the shoulders of Service Users. More research is needed to address this issue.



中文翻译:

重新开始对话:改善抗精神病药物处方中的共同决策

摘要

共享决策 (SDM) 是以患者为中心的护理的关键组成部分之一。被诊断患有精神分裂症/精神病的人仍然面临着实现这一目标的重大障碍,尤其是在抗精神病药物处方方面。这些障碍包括耻辱感、胁迫感和缺乏信息等问题。临床医生还描述了在抗精神病药处方中实现 SDM 的障碍,包括缺乏培训和支持。在这篇观点文章中,我们从服务用户和临床医生的角度总结了这些障碍。我们建议,为了向实现 SDM 迈出切实可行的第一步,需要重新开始围绕抗精神病药物处方的对话。但是,这样做的责任不应完全由服务用户承担。

更新日期:2021-03-27
down
wechat
bug